223 related articles for article (PubMed ID: 36490346)
21. Research resource: transcriptional response to glucocorticoids in childhood acute lymphoblastic leukemia.
Rainer J; Lelong J; Bindreither D; Mantinger C; Ploner C; Geley S; Kofler R
Mol Endocrinol; 2012 Jan; 26(1):178-93. PubMed ID: 22074950
[TBL] [Abstract][Full Text] [Related]
22. Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children.
Koga Y; Matsuzaki A; Suminoe A; Hattori H; Kanemitsu S; Hara T
Pediatr Blood Cancer; 2005 Aug; 45(2):121-7. PubMed ID: 15704223
[TBL] [Abstract][Full Text] [Related]
23. Glucocorticoid-induced apoptosis and glucocorticoid resistance in acute lymphoblastic leukemia.
Ploner C; Schmidt S; Presul E; Renner K; Schröcksnadel K; Rainer J; Riml S; Kofler R
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):153-60. PubMed ID: 15860257
[TBL] [Abstract][Full Text] [Related]
24. Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia.
Chen DW; Saha V; Liu JZ; Schwartz JM; Krstic-Demonacos M
Oncogene; 2013 Jun; 32(25):3039-48. PubMed ID: 22869147
[TBL] [Abstract][Full Text] [Related]
25. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor.
Liang YN; Tang YL; Ke ZY; Chen YQ; Luo XQ; Zhang H; Huang LB
J Steroid Biochem Mol Biol; 2017 Sep; 172():62-68. PubMed ID: 28578002
[TBL] [Abstract][Full Text] [Related]
26. The regulation of NONO by USP11 via deubiquitination is linked to the proliferation of melanoma cells.
Feng P; Li L; Dai J; Zhou L; Liu J; Zhao J; Li X; Ling N; Qiu S; Zhang L; Xie T; Chen Y; Donovan MJ; Peng T; Song J; Ye M
J Cell Mol Med; 2021 Feb; 25(3):1507-1517. PubMed ID: 33369124
[TBL] [Abstract][Full Text] [Related]
27. Protein kinase C plays a role in the induction of tyrosine phosphorylation of lymphoid microtubule-associated protein-2 kinase. Evidence for a CD3-associated cascade that includes pp56lck and that is defective in HPB-ALL.
Nel AE; Hanekom C; Hultin L
J Immunol; 1991 Sep; 147(6):1933-9. PubMed ID: 1716287
[TBL] [Abstract][Full Text] [Related]
28. Identification and Characterization of USP7 Targets in Cancer Cells.
Georges A; Marcon E; Greenblatt J; Frappier L
Sci Rep; 2018 Oct; 8(1):15833. PubMed ID: 30367141
[TBL] [Abstract][Full Text] [Related]
29. TRIM32/USP11 Balances ARID1A Stability and the Oncogenic/Tumor-Suppressive Status of Squamous Cell Carcinoma.
Luo Q; Wu X; Nan Y; Chang W; Zhao P; Zhang Y; Su D; Liu Z
Cell Rep; 2020 Jan; 30(1):98-111.e5. PubMed ID: 31914402
[TBL] [Abstract][Full Text] [Related]
30. Glucocorticoids Inhibit Oncogenic RUNX1-ETO in Acute Myeloid Leukemia with Chromosome Translocation t(8;21).
Lu L; Wen Y; Yao Y; Chen F; Wang G; Wu F; Wu J; Narayanan P; Redell M; Mo Q; Song Y
Theranostics; 2018; 8(8):2189-2201. PubMed ID: 29721072
[TBL] [Abstract][Full Text] [Related]
31. CRLF2 rearrangement in Ph-like acute lymphoblastic leukemia predicts relative glucocorticoid resistance that is overcome with MEK or Akt inhibition.
Meyer LK; Delgado-Martin C; Maude SL; Shannon KM; Teachey DT; Hermiston ML
PLoS One; 2019; 14(7):e0220026. PubMed ID: 31318944
[TBL] [Abstract][Full Text] [Related]
32. AKT1 has dual actions on the glucocorticoid receptor by cooperating with 14-3-3.
Habib T; Sadoun A; Nader N; Suzuki S; Liu W; Jithesh PV; Kino T
Mol Cell Endocrinol; 2017 Jan; 439():431-443. PubMed ID: 27717743
[TBL] [Abstract][Full Text] [Related]
33. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor.
Guo X; Zhou CY; Li Q; Gao J; Zhu YP; Gu L; Ma ZG
Biomed Environ Sci; 2013 May; 26(5):371-81. PubMed ID: 23611130
[TBL] [Abstract][Full Text] [Related]
34. Regulation of Bcl-3 through interaction with the Lck tyrosine kinase.
Zhao Y; Ramakrishnan A; Kim KE; Rabson AB
Biochem Biophys Res Commun; 2005 Sep; 335(3):865-73. PubMed ID: 16099425
[TBL] [Abstract][Full Text] [Related]
35. Glucocorticoid resistance in childhood leukemia.
Kaspers GJ; Pieters R; Klumper E; De Waal FC; Veerman AJ
Leuk Lymphoma; 1994 Apr; 13(3-4):187-201. PubMed ID: 8049644
[TBL] [Abstract][Full Text] [Related]
36. Tyrosine kinase, p56lck-induced cell motility, and urokinase-type plasminogen activator secretion involve activation of epidermal growth factor receptor/extracellular signal regulated kinase pathways.
Mahabeleshwar GH; Das R; Kundu GC
J Biol Chem; 2004 Mar; 279(11):9733-42. PubMed ID: 14699120
[TBL] [Abstract][Full Text] [Related]
37. Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in Leukemia.
Zhou Y; Han C; Wang E; Lorch AH; Serafin V; Cho BK; Gutierrez Diaz BT; Calvo J; Fang C; Khodadadi-Jamayran A; Tabaglio T; Marier C; Kuchmiy A; Sun L; Yacu G; Filip SK; Jin Q; Takahashi YH; Amici DR; Rendleman EJ; Rawat R; Bresolin S; Paganin M; Zhang C; Li H; Kandela I; Politanska Y; Abdala-Valencia H; Mendillo ML; Zhu P; Palhais B; Van Vlierberghe P; Taghon T; Aifantis I; Goo YA; Guccione E; Heguy A; Tsirigos A; Wee KB; Mishra RK; Pflumio F; Accordi B; Basso G; Ntziachristos P
Cancer Discov; 2020 Sep; 10(9):1388-1409. PubMed ID: 32444465
[TBL] [Abstract][Full Text] [Related]
38. An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-α and cAMP/PKA pathways.
Lv M; Zhang X; Jia H; Li D; Zhang B; Zhang H; Hong M; Jiang T; Jiang Q; Lu J; Huang X; Huang B
Leukemia; 2012 Apr; 26(4):769-77. PubMed ID: 21979877
[TBL] [Abstract][Full Text] [Related]
39. High level resistance to glucocorticoids, associated with a dysfunctional glucocorticoid receptor, in childhood acute lymphoblastic leukemia cells selected for methotrexate resistance.
Catts VS; Farnsworth ML; Haber M; Norris MD; Lutze-Mann LH; Lock RB
Leukemia; 2001 Jun; 15(6):929-35. PubMed ID: 11417479
[TBL] [Abstract][Full Text] [Related]
40. An oncogenic tyrosine kinase inhibits DNA repair and DNA-damage-induced Bcl-xL deamidation in T cell transformation.
Zhao R; Yang FT; Alexander DR
Cancer Cell; 2004 Jan; 5(1):37-49. PubMed ID: 14749125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
